IFP Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History

IFP Advisors’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,253	Closed	-$1K	–	4329
2016 Q3	$1K	Hold	2,253	–	–	﹤0.01%	3862
2016 Q2	$1K	Buy	+2,253	New	+$1K	﹤0.01%	3785
2016 Q1	–	Sell	-1,253	Closed	-$2K	–	4369
2015 Q4	$2K	Buy	+1,253	New	+$2K	﹤0.01%	3453

IFP Advisors's RXII Position: Q4 2016 in Review

IFP Advisors sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 2,253 shares — an estimated $1K sold.

IFP Advisors first reported a position in RXII in Q4 2015 and held it in 3 quarters. The position peaked at $2K in Q4 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

IFP Advisors reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
IFP Advisors sold 2,253 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $1K.
IFP Advisors first reported a position in GALENA BIOPHARMA INC COM in Q4 2015 and held it in 3 quarters.
IFP Advisors's GALENA BIOPHARMA INC COM position peaked at $2K in Q4 2015.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on IFP Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.